Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate CONMED Corporation before investing.

In this article, we go over a few key elements for understanding CONMED Corporation’s stock price such as:

• CONMED Corporation’s current stock price and volume
• Why CONMED Corporation’s stock price changed recently
• Upgrades and downgrades for CNMD from analysts
• CNMD’s stock price momentum as measured by its relative strength

About CONMED Corporation (CNMD)

Before we jump into CONMED Corporation’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Want to learn more about CONMED Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about CONMED Corporation.

What Caused CONMED Corporation Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 29, 2026, there was 1 analyst who downgraded CONMED Corporation’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate CONMED Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on CONMED Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

CONMED Corporation’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about CONMED Corporation (CNMD) by visiting AAII Stock Evaluator.

Relative Price Strength of CONMED Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 29, 2026, CONMED Corporation has a weighted four-quarter relative price strength of -18.50%, which translates to a Momentum Score of 12 and is considered to be Very Weak.

Want to learn more about how CONMED Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

CONMED Corporation Stock Price: Bottom Line

As of June 1, 2026, CONMED Corporation’s stock price is $35.600, which is down 0.28% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like CONMED Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.